{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T21:41:23Z","timestamp":1776721283822,"version":"3.51.2"},"reference-count":41,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0510034"],"award-info":[{"award-number":["JP21ek0510034"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["JPMJSP2125"],"award-info":[{"award-number":["JPMJSP2125"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.jtct.2023.09.010","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T03:34:13Z","timestamp":1695267253000},"page":"768.e1-768.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-3522-2278","authenticated-orcid":false,"given":"Marie","family":"Ohbiki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1407-2393","authenticated-orcid":false,"given":"Yuri","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4881-0427","authenticated-orcid":false,"given":"Yoshihiro","family":"Inamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Miyamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5952-5926","authenticated-orcid":false,"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayasu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8814-230X","authenticated-orcid":false,"given":"Masatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiro","family":"Kawakita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5421-7470","authenticated-orcid":false,"given":"Kazuhiro","family":"Ikegame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9609-3202","authenticated-orcid":false,"given":"Takahide","family":"Ara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0393-4066","authenticated-orcid":false,"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kiyoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-2870","authenticated-orcid":false,"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.09.010_bib0001","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41409-019-0624-z","article-title":"Death after hematopoietic stem cell transplantation: changes over calendar year time, infections and associated factors","volume":"55","author":"Styczy\u0144ski","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0002","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.09.010_bib0003","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/M19-2936","article-title":"Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003-2007 versus 2013-2017 cohorts","volume":"172","author":"McDonald","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtct.2023.09.010_bib0004","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2012.46.6193","article-title":"Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors","volume":"31","author":"Hahn","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0005","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1182\/bloodadvances.2020003418","article-title":"How much has allogeneic stem cell transplant-related mortality improved since the 1980s? A retrospective analysis from the EBMT","volume":"4","author":"Penack","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.09.010_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1532\/IJH97.06239","article-title":"Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System","volume":"86","author":"Atsuta","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0007","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.09.010_bib0008","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37,513,025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jtct.2023.09.010_bib0009","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S2352-4642(22)00095-5","article-title":"Worldwide trends in population-based survival for children, adolescents, and young adults diagnosed with leukaemia, by subtype, during 2000-14 (CONCORD-3): analysis of individual data from 258 cancer registries in 61 countries","volume":"6","author":"Ssenyonga","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/j.jtct.2023.09.010_bib0010","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3109\/0284186X.2014.912350","article-title":"Socioeconomic inequalities in cancer survival: a population-based study of adult patients diagnosed in Osaka, Japan, during the period 1993-2004","volume":"53","author":"Ito","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0011","unstructured":"Japan NCC. https:\/\/ganjoho.jp\/reg_stat\/statistics\/data\/cohort\/index.html (July 9th, 2023). 2021."},{"key":"10.1016\/j.jtct.2023.09.010_bib0012","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1541-0420.2011.01640.x","article-title":"On estimation in relative survival","volume":"68","author":"Perme","year":"2012","journal-title":"Biometrics"},{"key":"10.1016\/j.jtct.2023.09.010_bib0013","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1177\/1536867X1501500112","article-title":"Estimating and modeling relative survival","volume":"15","author":"Dickman","year":"2015","journal-title":"Stata J"},{"key":"10.1016\/j.jtct.2023.09.010_bib0014","series-title":"Stata statistical software. Stata 14. College Station","year":"2015"},{"key":"10.1016\/j.jtct.2023.09.010_bib0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ejca.2003.10.013","article-title":"Period analysis for \u2018up-to-date\u2019 cancer survival data: theory, empirical evaluation, computational realisation and applications","volume":"40","author":"Brenner","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtct.2023.09.010_bib0016","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1111\/cas.12525","article-title":"Long-term survival and conditional survival of cancer patients in Japan using population-based cancer registry data","volume":"105","author":"Ito","year":"2014","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jtct.2023.09.010_bib0017","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1182\/bloodadvances.2022008032","article-title":"Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades","volume":"6","author":"Nishiwaki","year":"2022","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.09.010_bib0018","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","article-title":"Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century","volume":"113","author":"Pulte","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.09.010_bib0019","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ajh.26156","article-title":"Acute lymphoblastic leukemia: a population-based study of outcome in the United States based on the surveillance, epidemiology, and end results (SEER) database, 1980-2017","volume":"96","author":"Sasaki","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0020","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/hon.3000","article-title":"The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation","volume":"40","author":"Shimazu","year":"2022","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0021","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bmt.2012.172","article-title":"Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia\/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry","volume":"48","author":"Kurosawa","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0022","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41409-018-0301-7","article-title":"Patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation: trends in survival during the past two decades","volume":"54","author":"Yanada","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0023","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/bcj.2013.57","article-title":"Association between decreasing trend in the mortality of adult T-cell leukemia\/lymphoma and allogeneic hematopoietic stem cell transplants in Japan: analysis of Japanese vital statistics and Japan Society for Hematopoietic Cell Transplantation (JSHCT)","volume":"3","author":"Chihara","year":"2013","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2023.09.010_bib0024","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bmt.2015.265","article-title":"Early application of related SCT might improve clinical outcome in adult T-cell leukemia\/lymphoma","volume":"51","author":"Fuji","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0025","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.bbmt.2005.09.012","volume":"12","author":"Rizzo","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0026","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0027","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1200\/JCO.2005.09.020","article-title":"Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0028","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s12185-010-0581-1","article-title":"Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry","volume":"91","author":"Nagafuji","year":"2010","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0029","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.bbmt.2019.09.036","article-title":"Time-varying effects of graft type on outcomes for patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantation","volume":"26","author":"Yanada","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0030","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.09.010_bib0031","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1001\/jamaoncol.2016.2520","article-title":"Comparison of patient-reported outcomes in 5-year survivors who received bone marrow vs peripheral blood unrelated donor transplantation: long-term follow-up of a randomized clinical trial","volume":"2","author":"Lee","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0032","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1056\/NEJMoa1506002","article-title":"Antilymphocyte globulin for prevention of chronic graft-versus-host disease","volume":"374","author":"Kr\u00f6ger","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.09.010_bib0033","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1200\/JCO.20.00150","article-title":"Antithymocyte globulin for matched sibling donor transplantation in patients with hematologic malignancies: a multicenter, open-label, randomized controlled study","volume":"38","author":"Chang","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0034","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/ajh.26320","article-title":"Low-dose thymoglobulin for prevention of chronic graft-versus-host disease in transplantation from an HLA-matched sibling donor","volume":"96","author":"Cho","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0035","doi-asserted-by":"crossref","first-page":"153.e1","DOI":"10.1016\/j.jtct.2021.12.009","article-title":"Antithymocyte globulin potentially could overcome an adverse effect of acute graft-versus-host disease in matched-related peripheral blood stem cell transplantation","volume":"28","author":"Miyao","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.09.010_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100792","article-title":"Graft-versus-host disease prophylaxis: pathophysiology-based review on current approaches and future directions","volume":"48","author":"Martinez-Cibrian","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.jtct.2023.09.010_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1057694","article-title":"Controversies and expectations for the prevention of GVHD: a biological and clinical perspective","volume":"13","author":"Watkins","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jtct.2023.09.010_bib0038","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.2021015129","article-title":"How I prevent GVHD in high-risk patients: posttransplant cyclophosphamide and beyond","volume":"141","author":"Rimando","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.09.010_bib0039","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41408-022-00678-6","article-title":"Improved trends in survival and engraftment after single cord blood transplantation for adult acute myeloid leukemia","volume":"12","author":"Konuma","year":"2022","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtct.2023.09.010_bib0040","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.bbmt.2015.10.006","article-title":"Comparison of outcomes of 8\/8 and 7\/8 allele-matched unrelated bone marrow transplantation and single-unit cord blood transplantation in adults with acute leukemia","volume":"22","author":"Terakura","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.09.010_bib0041","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41375-019-0534-5","article-title":"Prognostic factors for adult single cord blood transplantation among European and Japanese populations: the Eurocord\/ALWP-EBMT and JSHCT\/JDCHCT collaborative study","volume":"34","author":"Kanda","year":"2020","journal-title":"Leukemia"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723015518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:53Z","timestamp":1763003513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723015518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":41,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2666636723015518"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.09.010","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved Long-Term Net Survival after Allogeneic Hematopoietic Cell Transplantation in Patients with Hematologic Malignancies over Two Decades","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.09.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}